Skip to main content
. 2019 Jul 17;221(3):356–366. doi: 10.1093/infdis/jiz152

Table 2.

Results From Mixed-Effects Negative Binomial Regression Analyses

Variable Unadjusted, IRR (95% CI) Adjusted,a IRR (95% CI)
Primary analysis: NAI treatment on day of hospital admission vs later/no NAI treatmentb
 Overall 0.83 (.79–.87)c 0.81 (.78–.85)c
 Laboratory-confirmed A(H1N1)pdm09 infection 0.83 (.79–.86)c 0.81 (.77–.85)c
 Children (age <16 y) 0.90 (.83–.97)c 0.85 (.78–.92)c
 Elderly (age ≥65 y) 0.78 (.67–.91)c 0.78 (.67–.91)c
 Patients requiring standard ward-based care only 0.81 (.77–.85)c 0.81 (.78–.86)c
 ICU-admitted patients onlyd 0.80 (.73–.88)c 0.79 (.72–.87)c
 Confirmed absence of influenza-related pneumonia 0.71 (.66–.77)c 0.73 (.68–.79)c
 Confirmed presence of influenza-related pneumonia 0.91 (.84–.98)c 0.85 (.79–.93)c
Sensitivity analysis: NAI treatment on day of hospital admission vs no NAI treatmentb
 Overall 1.14 (1.07–1.22)c 1.06 (.99–1.13)
 Laboratory-confirmed A(H1N1)pdm09 infection 1.15 (1.07–1.22)c 1.04 (.97–1.12)
 Children (age <16 y) 1.09 (.98–1.20) 0.98 (.88–1.09)
 Elderly (age ≥65 y) 0.84 (.67–1.06) 0.83 (.65–1.07)
 Patients requiring standard ward-based care only 0.93 (.87–.99)c 0.92 (.85–.98)c
 ICU-admitted patients onlyd 1.14 (.96–1.36) 1.08 (.90–1.31)
 Confirmed absence of influenza-related pneumonia 0.83 (.75–.92)c 0.81 (.73–.90)c
 Confirmed presence of influenza-related pneumonia 1.28 (1.12–1.47)c 1.28 (1.11–1.48)c
Secondary analyses
 NAI anytime vs no NAI treatment
  Overall 1.21 (1.17–1.26)c 1.11 (1.07–1.16)c
  Laboratory-confirmed A(H1N1)pdm09 infection 1.31 (1.25–1.37)c 1.17 (1.12–1.23)c
  Children (age <16 y) 1.18 (1.11–1.25)c 1.11 (1.04–1.18)c
  Elderly patients (age ≥65 y) 1.00 (.86–1.17) 0.98 (.83–1.14)
  Patients requiring standard ward-based care only 1.06 (1.02–1.10)c 1.02 (.98–1.05)
  ICU-admitted patients onlyd 1.33 (1.19–1.49)c 1.26 (1.13–1.41)c
  Confirmed absence of influenza-related pneumonia 0.98 (.90–1.07) 0.97 (.89–1.06)
  Confirmed presence of influenza-related pneumonia 1.36 (1.24–1.49)c 1.28 (1.16–1.40)c
 Early NAI treatment vs later NAI treatment
  Overall 0.70 (.68–.73)c 0.77 (.74–.80)c
  Laboratory-confirmed A(H1N1)pdm09 infection 0.70 (.68–.73)c 0.77 (.74–.80)c
  Children (age <16 y) 0.80 (.74–.86)c 0.87 (.81–.93)c
  Elderly patients (age ≥65 y) 0.71 (.62–.81)c 0.71 (.62–.82)c
  Patients requiring standard ward-based care only 0.78 (.75–.81)c 0.83 (.79–.86)c
  ICU-admitted patients onlyd 0.69 (.64–.74)c 0.74 (.69–.80)c
  Confirmed absence of influenza-related pneumonia 0.80 (.75–.86)c 0.84 (.78–.90)c
  Confirmed presence of influenza-related pneumonia 0.84 (.78–.90)c 0.82 (.77–.88)c
 Early NAI treatment vs no NAI treatment
  Overall 1.04 (.98–1.11) 0.93 (.87–.99)c
  Laboratory-confirmed A(H1N1)pdm09 infection 1.05 (.98–1.11) 0.93 (.87–.99)c
  Children (age <16 y) 1.00 (.91–1.10) 0.92 (.83–1.01)
  Elderly patients (age ≥65 y) 0.82 (.67–1.01) 0.79 (.63–.997)c
  Patients requiring standard ward-based care only 0.93 (.87–.99)c 0.88 (.82–.94)c
  ICU-admitted patients onlyd 1.01 (.86–1.20) 0.93 (.79–1.10)
  Confirmed absence of influenza-related pneumonia 0.79 (.71–.89)c 0.76 (.68–.85)c
  Confirmed presence of influenza-related pneumonia 1.09 (.95–1.24) 1.01 (.88–1.16)

Abbreviations: A(H1N1)pdm09, 2009 pandemic influenza A(H1N1) virus; CI, confidence interval; IRR, incidence rate ratio; NAI, neuraminidase inhibitor.

aAdjusted for propensity scores (quintiles) for receiving treatment, antibiotic treatment received in the hospital, and steroid treatment received in the hospital.

bThe IRR was further adjusted for time from onset to admission.

cStatistically significant (P < .05).

dData are for patients admitted to the ICU at any point. The IRR was calculated for the total length of hospital stay, not time in the ICU. Our sensitivity analyses and secondary analyses must be interpreted with caution because they may be affected by various time-dependent biases